0.163
-0.00685 (-4.03%)
-0.00685 (-4.03%)
Upgrade to Real-Time
Market Open
Low
0.135
High
0.60
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cannibics Pharmaceuticals Inc (QB) | CNBX | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.00685 | -4.03% | 0.163 | 13:15:31 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.18745 | 0.160223 | 0.18745 | 0.16985 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.161 | 0.163 | 0.002 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 44 | 59,113 | $ 0.165368 | $ 9,775 | - | 0.135 - 0.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:15:31 | 3,201 | $ 0.163 | USD |
Period:
Draw Mode:
Cannibics Pharmaceuticals Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 23.91M | 146.66M | 47.53M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 41.54k | $ - | - | - | - |
Cannibics Pharmaceuticals (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CNBX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.17295 | 0.18745 | 0.157 | 0.1707341 | 118,124 | -0.00995 | -5.75% |
| 1 Month | 0.1801 | 0.198 | 0.157 | 0.1802898 | 128,590 | -0.0171 | -9.49% |
| 3 Months | 0.21 | 0.233 | 0.1536 | 0.1906995 | 167,730 | -0.047 | -22.38% |
| 6 Months | 0.29 | 0.60 | 0.1536 | 0.3164029 | 346,738 | -0.127 | -43.79% |
| 1 Year | 0.212 | 0.60 | 0.135 | 0.2896807 | 268,266 | -0.049 | -23.11% |
| 3 Years | 0.91 | 1.35 | 0.066 | 0.3913223 | 264,567 | -0.747 | -82.09% |
| 5 Years | 0.0505 | 7.60 | 0.035 | 1.19 | 359,070 | 0.1125 | 222.77% |
Cannibics Pharmaceuticals (QB) Description
| Cannabics Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company specializing in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. We combine the power of our proprietary technologies with the expertise of our leading scientists to unlock the medicinal properties of cannabis and its diversity of bioactive compounds. We have conducted thousands of tests on biopsies and cell lines in order to identify the physiologic impact of cannabinoids on cell cycle and cell death. Our core technology is a continuously evolving bioinformatics platform that utilizes high throughput screening technology, advanced data analytics, artificial intelligence and proprietary methodologies to rapidly examine the physiologic impact of multiple cannabinoid compounds on tumor cells. |
